Trial intelligence / Profile preview

Allopurinol as add-on to antipsychotics in schizophrenia

NCT00864825Phase 4Completed

Sponsor
Sheba Medical Center
Start
Aug 2009
Primary completion
Dec 2009
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of allopurinol in schizophrenia, schizoaffective disorder, sponsored by Sheba Medical Center. Started Aug 2009; status: completed.

02

Drugs

allopurinol
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT00864825.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00864825.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call